Brief Report: Leucine‐Rich α2‐Glycoprotein as a Potential Biomarker for Joint Inflammation During Anti–Interleukin‐6 Biologic Therapy in Rheumatoid Arthritis

Publisher: John Wiley & Sons Inc

E-ISSN: 2326-5205|67|8|2056-2060

ISSN: 2326-5191

Source: ARTHRITIS & RHEUMATOLOGY, Vol.67, Iss.8, 2015-05, pp. : 2056-2060

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content